Drawdown Insights
Data-driven market analysis powered by 40 years of drawdown history. Know when stocks are on sale, and what history says happens next.
Page 35 of 38
Republic Services Is Down 20%. Is a Recovery Near?
RSG has a 5.1 severity score after falling 20% over 279 days. Learn why this drawdown is significantly longer than its 35 day average.
SAP Down 45% in 300 Days. Is This a Major Turning Point?
SAP has a Drawdown Severity Score of 8.8. The stock has fallen 45% from its peak over 296 days, far exceeding its average 70 day decline duration.
SAP Is Down 45% in 300 Days. Is It Time to Buy?
SAP has a Drawdown Severity Score of 8.8. The stock is down 45% from its high, trading at $171 after a 296 day sell-off that exceeds historical norms.
SH is Down 94% Over 6,000 Days. Is the Bottom Finally In?
ProShares Short S&P500 (SH) hit a severity score of 16.4. The asset is down 94% from its high over a 6,262 day period.
Stryker is Down 27% Over 200 Days. Is a Recovery Coming?
Stryker (SYK) has a drawdown severity score of 5.2. The stock is down 26.8% from its high, significantly exceeding its historical average drop of 5.3%.
Sunstone Hotel Investors Is Down 30%. Is It Time to Buy?
Sunstone Hotel Investors (SHO) has a 7.4 severity score. The stock is down 30% from its high, far exceeding its typical 3% average drawdown.
GOOGL Hits New Highs. Is the Recovery Finally Complete?
Alphabet Inc. (GOOGL) reaches a 0.0 Drawdown Severity Score and a new high of $384. Cloud growth has erased the previous average max drawdown of 4.3%.
Is Aon's 23% Drop a Rare Discount or a New Reality?
Aon (AON) hits a 5.4 severity score after a 376-day slide. The stock is down 23% from its high, far exceeding its typical 4% average drawdown.
Is Eli Lilly's 16% Drop Over After 100 Days of Selling?
Eli Lilly (LLY) holds a 3.1 severity score after a -15.8% decline. The stock has spent 106 days in a drawdown, exceeding its 62-day historical average.
Is Meta's 22% Drop Over? What History Says About This Sell-Off
Meta has a Drawdown Severity Score of 4.3. The stock has fallen 22% from its peak over a 205 day period as AI spending concerns mount.
Is Qualcomm's 600 Day Slump Finally Over?
QCOM holds a 3.0 severity score after 626 days in drawdown. With an 18.7% drop from its peak, is the semiconductor giant finally stabilizing?
WTW Is Down 27% in 160 Days. Is This a Fundamental Shift?
WTW has a Drawdown Severity Score of 5.3. The stock is down 27% from its $350 peak, a decline 5x larger than its historical average of 5%.
XT Hits New Highs. Is the Tech Recovery Just Starting?
XT reaches a record $77 with a drawdown severity score of 0.0. The fund has spent 0 days in its current drawdown after a full recovery.
Is ResMed's 30% Drop a Value Trap or a Recovery Play?
ResMed (RMD) has a Drawdown Severity Score of 5.2. The stock is down 28% over 200 days, significantly exceeding its historical average drawdown of 6%.
Is Visa's 10% Drop Over After 260 Days in the Red?
Visa (V) shows a severity score of 2.5 after a 266 day drawdown. The stock fell 10% from its $373 peak but is now showing signs of technical stabilization.
Is Alcoa's 33% Drop a Red Flag or a Rare Discount?
Alcoa (AA) has a Drawdown Severity Score of 5.7. The stock is down 33% from its $94 high, a decline 4 times larger than its typical historical pullback.
Is IDXX a Buy After Dropping 26% From Its High?
IDXX has a Drawdown Severity Score of 5.1. The stock is down 26% from its high, a move five times more severe than its typical 5% pullback.
Is Pentair's 26% Drop a Warning Sign for Investors?
Pentair (PNR) hits a 5.0 severity score after falling 26% from its high. The current 182-day slide is more than double its 70-day historical average.
Is S&P Global's 23% Drop a Warning Sign for Investors?
S&P Global (SPGI) has a Drawdown Severity Score of 5.1. The stock is currently 23% below its all-time high, a decline lasting over 200 days.
BMN Drops 7% in 40 Days: Is This a Rare Buying Opportunity?
BMN has a 2.2 drawdown severity score after falling 6.7% from its high. This decline is triple its historical average drawdown of 1.9%.
Is AstraZeneca's 10% Drop a Warning Sign or a Buying Chance?
AstraZeneca (AZN) has a Drawdown Severity Score of 2.1. The stock is down 10% from its peak, exceeding its historical average decline of 5%.
Is Cintas a Buy After This Rare 23% Drop?
Cintas (CTAS) hits a 5.1 severity score after falling 23% from its high. This 276 day decline is nearly six times larger than its historical average.
Is Monster Beverage's 11% Slide a Warning of a 50% Crash?
MNST has a Drawdown Severity Score of 2.1. The stock is down 11% from its high, nearly double its historical average drawdown of 6%.
Is NuScale's 76% Drop a Bottom or a Trap for SMR Investors?
NuScale Power (SMR) has a 10.9 drawdown severity score. After falling 76% from its $53 peak, the stock has been in a continuous decline for 140 days.